Compound Kushen injection combined with platinum-based chemotherapy for stage III/IV non-small cell lung cancer: A meta-analysis of 37 RCTs following the PRISMA guidelines

Conclusions: From the available evidence, our data indicate that CKI plus platinum-based chemotherapy is more effective in improving clinical efficacy and alleviating the toxicity of chemotherapy than platinum-based chemotherapy alone in the treatment of stage III/IV NSCLC. However, considering the intrinsic limitations of the included trials, high-quality RCTs with survival outcomes are still needed to further confirm our findings.

Source: Journal of Cancer - July 2, 2020 Category: Cancer & Oncology Authors: Hongwei Chen, Xiaojun Yao, Ting Li, Christopher Wai-Kei Lam, Ruonan Zhang, Huixia Zhang, Jue Wang, Wei Zhang, Elaine Lai-Han Leung, Qibiao Wu Tags: Research Paper Source Type: research